Menu
Not yet recruiting NCT06523816

Dermoscopy and Histopathology in Non-melanocytic Skin Tumors

Observational Non-melanoma Skin Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: dermoscopy.
Who it may be relevant to
Registry conditions: Non-melanoma Skin Cancer. Basic parameters: No limits · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Center list to be confirmed — check the primary protocol.
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Correlation Between Dermoscopy and Histopathology in Non-melanocytic Skin Tumors

Overview

The main aim of the study is to investigate the relation between dermoscopic findings in pre-operative diagnosis of non-melanocytic skin tumors and post-operative histopathology findings .

Interventions

  • Diagnostic test dermoscopy
    Dermoscopy is a fast imaging technique that allows an excellent visualization of non-melanocytic skin tumors to diagnose them without invasive interventon.

Primary outcome measures

  • sensitivity of dermoscopy to detect NMSTs [Time frame: 2 years]

Eligibility criteria

Inclusion criteria

  • All patients with NMST clinically of both genders in all ages with positive dermoscopic findings and definite histopathologic diagnosis of NMST

Exclusion criteria

  • No exclusion criteria

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Case-only

Study locations

Center list to be confirmed — check the primary protocol.

Identifiers

NCT: NCT06523816 · NMSTs

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗